Mutations in other tumor-related genes were also identified in the sclerosing pneumocytoma, like PTEN, BRAF V600E, BLM, KMT2D, but with relatively smaller incidence than AKT1 and β-catenin [11, 41, 43]. The gene discussed is BRAF; the disease is lung sclerosing hemangioma.